Trifluoroacetic acid → HCID 25052322, compound
Reaction equation
C([NH:5][S:6]([C:9]1[CH:10]=[C:11]([C:15]2[CH:20]=[CH:19][CH:18]=[C:17]([C:21]3[CH2:22][C:23](=[O:39])[NH:24][C:25]4[CH:31]=[C:30]([C:32]5[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=5[F:38])[CH:29]=[CH:28][C:26]=4[N:27]=3)[CH:16]=2)[CH:12]=[CH:13][CH:14]=1)(=[O:8])=[O:7])(C)(C)C.C(O)(C(F)(F)F)=O>>[F:38][C:33]1[CH:34]=[CH:35][CH:36]=[CH:37][C:32]=1[C:30]1[CH:29]=[CH:28][C:26]2[N:27]=[C:21]([C:17]3[CH:16]=[C:15]([C:11]4[CH:12]=[CH:13][CH:14]=[C:9]([S:6]([NH2:5])(=[O:7])=[O:8])[CH:10]=4)[CH:20]=[CH:19][CH:18]=3)[CH2:22][C:23](=[O:39])[NH:24][C:25]=2[CH:31]=1Participants
3
Procedure
) The title compound was prepared from the above described 3′-[7-(2-fluoro-phenyl)-4-oxo-4,5-dihydro-3H-benzo[b][1,4]diazepin-2-yl]-biphenyl-3-sulfonic acid tert-butylamide (430 mg, 0.795 mmol) and TFA (5 mL) according to the general procedure I step 2. Obtained as a white solid (380 mg, 99%). MS (ISP) 486.0 [(M+H)+]; mp 230-232° C.
Sources & evidence
- ORD record
- ord-3aa9669757f74ea39d07bd98c7b1dab4
- Source dataset
- uspto-grants-2009_03
- Patent number
- US07511033B2
Reaction notes
Loading…